Page 36 - SOGBA_1_2022
P. 36

21.  Bianchi DW. Cherchez la femme:        ciated with  Hepatic  Adipose Con-
            maternal incidental findings can ex-     tent. J Clin Endocrinol Metab. mayo
            plain discordant prenatal cell-free      de 2005;90(5):2631–5.
            DNA sequencing results. Genet Med.     28.  Gawlik  A, Malecka-Tendera E.
            septiembre de 2018;20(9):910–7.          TRANSITION IN ENDOCRINOLO-
          22.  Wang  Y, Chen Y, Tian F,  Zhang  J,   GY: Treatment of Turner’s syndrome
            Song Z, Wu Y, et al. Maternal Mosai-     during transition. Eur J Endocrinol.
            cism Is a Significant Contributor to     febrero de 2014;170(2):R57–74.
            Discordant Sex Chromosomal Aneu-       29.  Bondy  C.  Recent Developments
            ploidies Associated with Noninvasi-      in Diagnosis  and  Care for Girls in
            ve Prenatal Testing. Clin Chem. 1 de     Turner Syndrome. Adv  Endocrinol.
            enero de 2014;60(1):251–9.               2014;2014:1–9.
          23.  Bianchi DW, Parsa S, Bhatt S, Halks-  30.  Spiliotis B. Recombinant human
            Miller  M,  Kurtzman  K,  Sehnert AJ,    growth  hormone in the treatment
            et al. Fetal Sex Chromosome Testing      of Turner syndrome. Ther Clin Risk
            by Maternal Plasma DNA Sequen-           Manag. diciembre de 2008;Volume
            cing: Clinical Laboratory Experience     4:1177–83.
            and Biology. Obstet Gynecol. febre-    31.  Baxter L, Bryant J, Cave CB, Milne
            ro de 2015;125(2):375–82.                R. Recombinant growth hormone
          24.  Sandow  R,  Scott  FP,  Schluter  PJ,   for children and adolescents with
            Rolnik DL, Menezes M, Nisbet D,          Turner  syndrome. Cochrane Me-
            et al. Increasing maternal age is not    tabolic and Endocrine  Disorders
            a  significant  cause  of  false-positive   Group, editor. Cochrane  Database
            results for monosomy X in non-inva-      Syst Rev [Internet]. 24 de enero de
            sive prenatal testing. Prenat Diagn.     2007 [citado 4 de enero de 2022];
            octubre de 2020;40(11):1466–73.          Disponible  en:  https://doi.wiley.
          25.  Shankar RK, Backeljauw PF. Current    com/10.1002/14651858.CD003887.
            best practice in the management of       pub2
            Turner syndrome. Ther Adv Endocri-     32.  Gravholt  CH,  Viuff  MH,  Brun  S,
            nol Metab. enero de 2018;9(1):33–40.     Stochholm K, Andersen NH. Turner
          26.  Ibarra-Ramírez M, Martínez-de-        syndrome: mechanisms  and mana-
            Villarreal LE. Clinical and  genetic     gement. Nat Rev Endocrinol. octu-
            aspects of Turner’s syndrome. Med        bre de 2019;15(10):601–14.
            Univ. enero de 2016;18(70):42–8.       33.  Klein  KO,  Rosenfield  RL,  Santen
          27.  Ostberg JE,  Thomas  EL,  Hamilton    RJ, Gawlik  AM, Backeljauw PF,
            G, Attar MJH, Bell JD, Conway GS.        Gravholt CH, et al. Estrogen Repla-
            Excess Visceral and Hepatic Adipo-       cement in Turner Syndrome:  Lite-
            se Tissue in Turner Syndrome De-         rature Review and Practical Consi-
            termined by Magnetic Resonance           derations. J Clin Endocrinol Metab.
            Imaging: Estrogen Deficiency Asso-       1 de mayo de 2018;103(5):1790–803.



          34                                                                                                                                                                       S.O.G.B.A.
   31   32   33   34   35   36   37   38   39   40   41